Background: Etamicastat is a novel, potent, and reversible peripheral dopamineb-hydroxylase inhibitor that has been administered orally at doses up to 600 mg once daily for 10 days to male healthy volunteers and appears to be well tolerated. Objective: The aim of this study was to investigate the effect of food on the pharmacokinetics of etamicastat. Material and Methods: A single-center, open-label, randomized, two-way crossover study in 12 healthy male subjects was performed. Subjects were administered a single dose of etamicastat 200 mg following either a standard high-fat and high-calorie content meal (test) or 10 hours of fasting (reference). The statistical method for testing the effect of food on the pharmacokinetic parameters of interest was based upon the 90% confidence interval (CI) for the test/reference geometric mean ratio (GMR). The parameters of interest were maximum plasma concentration (C max), area under the plasma concentration-time curve (AUC) from time zero to the last measurable concentration (AUC last), and AUC from time zero to infinity (AUC ¥). Bioequivalence was assumed when the 90% CI fell within the recommended acceptance interval (80, 125). Results: Etamicastat C max , AUC last , and AUC ¥ were 229 ng/mL, 1856 ng Á h/mL, and 2238 ng Á h/mL, respectively, following etamicastat in the fasting, and 166 ng/mL, 1737 ng Á h/mL, and 2119 ng Á h/mL, respectively, following etamicastat in the fed condition. Etamicastat test/reference GMR was 72.27% (90% CI 64.98, 80.38) for C max , 93.59% (90% CI 89.28, 98.11) for AUC last , and 96.47% (90% CI 91.67, 101.53) for AUC ¥. Time to C max was prolonged by the presence of food (p < 0.001). The C max , AUC last , and AUC ¥ values of the inactive metabolite BIA 5-961 were 275 ng/mL, 1827 ng Á h/mL, and 2009 ng Á h/mL, respectively, in the fasting, and 172 ng/mL, 1450 ng Á h/mL, and 1677 ng Á h/mL, respectively, in the fed condition. BIA 5-961 test/reference GMR was 62.42%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.